Study to Assess Efficacy and Safety of Three Oral Doses of Laquinimod

Study Title

A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of Laquinimod

Teva Identifier

TV5600-CNS-20007 | 2014-000418-75

ClinicalTrials.gov Identifier

NCT02215616

Study Status

Completed

Trial Condition(s)

Huntington's Disease

Interventions

Drug: Laquinimod | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

21 Years to 55 Years

Trial Duration

October 28, 2014 - June 19, 2018

Phase

Phase 2

Study Type

Interventional